心臓リハビリテーションにおける肥満: 心臓リハビリテーションプログラムの一部として体重管理を提供することに関する考慮事項

Codie R Rouleau¹, Chelsea Moran², Tamara M Williamson³

¹Department of Psychology, University of Calgary, AB; TotalCardiology Research Network, Calgary, AB.

The Canadian journal of cardiology

|September 6, 2025

まとめ

肥満の管理を心臓リハビリテーション (CR) に統合することは心臓血管の健康にとって極めて重要です. ほとんどのプロバイダがサポートしていますが訓練の必要性や重量偏差などの障壁を解決する必要があります

科学分野:

心臓病科
肥満医学
リハビリテーション科学

背景:

肥満は心臓血管の健康に重大な影響を及ぼしますが,心臓リハビリテーション (CR) ではしばしば見過ごされます.
患者の総合的なケアには過剰な体脂肪の治療が不可欠です
現在のCRプログラムでは肥満管理戦略はめったに組み込まれません

研究の目的:

標準的なCRに肥満管理を組み込むための証拠をレビューする.
CR内の肥満管理の成果,複雑さ,患者の視点を探求する.
肥満への介入をRCに統合するための障壁とファシリテーターを特定する.

主な方法:

肥満管理方法 (行動的,薬学的,外科的) に関する文献レビュー.
肥満管理の統合に関するカナダCRの医療提供者80人の調査.
結果,複雑さ,患者の経験を含むテーマの分析.

主要な成果:

ほとんどのCR提供者は (71%) 肥満管理をCRに統合することを支持しています.
主な懸念事項は,提供者訓練,体重偏差,非現実的な減量期待などです.
成果を最適化するために,証拠に基づいた戦略と長期のフォローアップが不可欠です.

結論:

肥満管理をCRに統合するには,提供者の懸念とリソースの制限に対処する必要があります.
患者の好み,実現可能性,有効性,費用対効果に関するさらなる研究が必要である.
提供者の能力とプログラムのリソースは,CRの肥満管理を提供するための重要な決定要因です.

キーワード:

行動による減量治療体重指数心臓リハビリテーション肥満肥満管理レビュー体重体重管理

さらに関連する動画

04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K

06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

947

関連する概念動画

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

01:24

Obesity

609

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

609

01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...

関連する実験動画